The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS

Summary

To determine safety and tolerance of administering aerosolized recombinant interferon gamma (IFN-gamma) for 4 weeks in patients with AIDS. To examine activation of alveolar macrophages by aerosolized IFN-gamma administration. To determine if subcutaneous (SC) injection of IFN-gamma can activate alveolar macrophages in AIDS patients.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications